한국동물위생학회지 (Korean Journal of Veterinary Service)

  • 제35권3호
  • /
  • Pages.191-195
  • /
  • 2012
  • /
  • 3022-7372(pISSN)
  • /
  • 2287-7630(eISSN)
한국동물위생학회 (The Korean Society of Veterinary Service)
권호 표지
DOI QR코드

DOI QR Code

Lipopolysaccharide로 유도한 패혈증 모델에서 Ginkgo biloba extract 투여가 생존율에 미치는 영향

Effect of Ginkgo biloba extract on the survival rate in lipopolysaccharide-induced sepsis model mice

  • 이기종 (연세대학교 보건과학대학 임상병리학과) ;
  • 김현철 (강원대학교 수의과대학) ;
  • 정배동 (강원대학교 수의과대학)
  • Rhee, Ki-Jong (Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University) ;
  • Kim, Hyeon-Cheol (College of Veterinary Medicine, Kangwon National University) ;
  • Jung, Bae-Dong (College of Veterinary Medicine, Kangwon National University)
  • 투고 : 2012.07.02
  • 심사 : 2012.08.13
  • 발행 : 2012.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Accumulated evidence indicate that Ginkgo biloba extract (EGb 761) acts as an antioxidant and scavenger of free radicals as well as influencing apoptotis. Earlier studies have employed the inflammatory agent lipopolysaccharide (LPS) to induce severe sepsis. In the present study, we examined whether the intraperitoneal injection of EGb 761 increases the survival rate of mice in the LPS-induced severe sepsis model. The survival rate was significantly increased by 30% in mice administered with 100 mg/kg of EGb 761 but not in mice administered with 50 mg/kg EGb 761. In addition, pre-treatment with EGb 761 increased the survival rate (30%) but post-treatment with EGb 761 did not. These results suggest that EGb 761 may have clinical potential in preventing sepsis induced mortality.

키워드

참고문헌

  1. Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K, Ulloa L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H. 2005. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46: 623-627. https://doi.org/10.1194/jlr.C400018-JLR200
  2. Di Giantomasso D, May CN, Bellomo R. 2003. Vital organ blood flow during hyperdynamic sepsis. Chest 124: 1053-1059. https://doi.org/10.1378/chest.124.3.1053
  3. Fink MP. 2007. Ethyl pyruvate: a novel treatment for sepsis. Curr Drug Targets 8: 515-518. https://doi.org/10.2174/138945007780362791
  4. Freise H, Brückner UB, Spiegel HU. 2001. Animal models of sepsis. J Invest Surg 14: 195-212. https://doi.org/10.1080/089419301750420232
  5. Haines DD, Bak I, Ferdinandy P, Mahmoud FF, Al-Harbi SA, Blasig IE, Tosaki A. 2000. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 35: 37-44. https://doi.org/10.1097/00005344-200001000-00005
  6. Ilhan A, Iraz M, Kamisli S, Yigitoglu R. 2006. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 761) in mice. Prog Neuropsychopharmcol Biol Psychiaty 30: 1504-1510. https://doi.org/10.1016/j.pnpbp.2006.05.013
  7. Kasper S, Schubert H. 2009. Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability. Fortschr Neurol Psychiatr 77: 494-506. https://doi.org/10.1055/s-0028-1109504
  8. Kotakadi VS, Jin Y, Hofseth AB, Ying L, Cui X, Volate S, Chumanevich A, Wood PA, Price RL, McNeal A, Singh UP, Singh NP, Nagarkatti M, Nagarkatti PS, Matesic LE, Auclair K, Wargovich MJ, Hofseth LJ. 2008. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 29: 1799-1806. https://doi.org/10.1093/carcin/bgn143
  9. Moore CC, Martin EN, Lee G, Taylor C, Dondero R, Reznikov LL, Dinarello C, Thompson J, Scheld WM. 2008. Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury. J Infec Dis 198: 1407-1414. https://doi.org/10.1086/592222
  10. Pittet JF, Pastor CM, Morel DR. 2003. Spontaneous high systemic oxygen delivery increase survival rate in awake sheep during sustained endotoxemia. Crit Care Med 28: 496-503.
  11. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P. 2008. Experimental models of sepsis and their clinical relevance. Shock 30: 53-59. https://doi.org/10.1097/SHK.0b013e318181a343
  12. Sener G, Omurtag GZ, Sehirli O, Tozan A, Yuksel M, Ercan F, Gedik N. 2006. Protective effects of ginkgo biloba against acetaminophen-induced toxicity in mice. Mol Cell Biochem 283: 39-45. https://doi.org/10.1007/s11010-006-2268-8
  13. Smith JV, Burdick A, Golik P, Khan I, Wallace D, Luo Y. 2002. Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol 48: 699-707.
  14. Smith JV, Luo Y. 2004. Studies on molecular mechanisms of Gingko biloba extract. Appl Microbiol Biotechnol 64: 465-472. https://doi.org/10.1007/s00253-003-1527-9

피인용 문헌

  1. Gingko biloba Extract Ameliorates Colonic Inflammation in DSS-induced Model of Colitis in Mice vol.20, pp.4, 2012, https://doi.org/10.15616/bsl.2014.20.4.227
  2. LPS에 의해 유도된 염증반응에서 섬애약쑥 추출물의 간보호 효과 vol.26, pp.11, 2012, https://doi.org/10.5352/jls.2016.26.11.1282